相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of exercise training on post-translational and post-transcriptional regulation of titin stiffness in striated muscle of wild type and IG KO mice
Carlos Hidalgo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice
Wenrui Huang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca2+ sensitivity and cross-bridge detachment kinetics
John Jeshurun Michael et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy
Katarzyna Kazmierczak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy
E. Rosalie Witjas-Paalberends et al.
CARDIOVASCULAR RESEARCH (2013)
Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene Mutations
Vasco Sequeira et al.
CIRCULATION RESEARCH (2013)
Diversity and similarity of motor function and cross-bridge kinetics in papillary muscles of transgenic mice carrying myosin regulatory light chain mutations D166V and R58Q
Li Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations
Li Wang et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2013)
Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice
Katarzyna Kazmierczak et al.
BIOCHEMICAL JOURNAL (2012)
Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2
Virgilio J. J. Cadete et al.
FEBS JOURNAL (2012)
AMP-activated Protein Kinase Phosphorylates Cardiac Troponin I at Ser-150 to Increase Myofilament Calcium Sensitivity and Blunt PKA-dependent Function
Benjamin R. Nixon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts
Priya Muthu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy
E. Dale Abel et al.
CARDIOVASCULAR RESEARCH (2011)
Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction
Priya Muthu et al.
FASEB JOURNAL (2011)
The Athlete's Heart vs. the Failing Heart: Can Signaling Explain the Two Distinct Outcomes?
Kate L. Weeks et al.
PHYSIOLOGY (2011)
Genetics of hypertrophic cardiomyopathy
Tetsuo Konno et al.
CURRENT OPINION IN CARDIOLOGY (2010)
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy
Anita C. Hoskins et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Hypertrophic Cardiomyopathy
Carolyn Y. Ho
Heart Failure Clinics (2010)
Cardiac Myosin Binding Protein-C Phosphorylation in a β-Myosin Heavy Chain Background
Sakthivel Sadayappan et al.
CIRCULATION (2009)
Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction
Sabine J. van Dijk et al.
CIRCULATION (2009)
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
Michelle Michels et al.
EUROPEAN HEART JOURNAL (2009)
The Role of the N-Terminus of the Myosin Essential Light Chain in Cardiac Muscle Contraction
Katarzyna Kazmierczak et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Augmented protein kinase C-α-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure
Rashad J. Belin et al.
CIRCULATION RESEARCH (2007)
Molecular modeling of the myosin-S1(A1) isoform
Ewald M. Aydt et al.
JOURNAL OF STRUCTURAL BIOLOGY (2007)
Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiac titin isoforms with high compliance
Yiming Wu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Myosin essential light chain in health and disease
Olga M. Hernandez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Expanding the range of free calcium regulation in biological solutions
D Dweck et al.
ANALYTICAL BIOCHEMISTRY (2005)
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury - A new intracellular target for matrix metalloproteinase-2
G Sawicki et al.
CIRCULATION (2005)
Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction
O Cazorla et al.
FASEB JOURNAL (2004)
Duration-controlled swimming exercise training induces cardiac hypertrophy in mice
FS Evangelista et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
Fine tuning the myosin motor: the role of the essential light chain in striated muscle myosin
DJ Timson
BIOCHIMIE (2003)
Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles
GM Diffee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Ca2+ transport ATPase isoforms SERCA2a and SERCA2b are targeted to the same sites in the murine heart
P Vangheluwe et al.
CELL CALCIUM (2003)
Natriuretic peptides: markers or modulators of cardiac hypertrophy?
DG Gardner
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases
T Tsuruda et al.
CIRCULATION RESEARCH (2002)
B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure
M Yoshimura et al.
AMERICAN JOURNAL OF MEDICINE (2002)
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure
SC Lee et al.
JOURNAL OF CARDIAC FAILURE (2002)
Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy
WH Lee et al.
AMERICAN HEART JOURNAL (2001)
分享论文
